eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2021
vol. 17
 
Share:
Send email
Share:
abstract:
Image in intervention

Thin-strut bioresorbable-polymer sirolimus-eluting stent use for an optimal result of rescue coronary angioplasty in acute myocardial infarction failed thrombolytic therapy: the Bangladesh National Heart Foundation Annual Conference OCT-assisted live case

Fazila-Tun-Nesa Malik
1
,
Ashok Dutta
1
,
Dhiman Banik
1
,
Tawfiq Shahriar Huq
1
,
Muhammad Kalimuddin
1
,
Filip Mikołajczyk
2
,
Piotr Musialek
3

  1. Department of Cardiology, National Heart Foundation Hospital & Research Institute, Dhaka, Bangladesh
  2. KCRI, Krakow, Poland
  3. Department of Cardiac and Vascular Diseases, Jagiellonian University, John Paul II Hospital, Krakow, Poland
Adv Interv Cardiol 2021; 17, 3 (65): 309–312
DOI: https://doi.org/10.5114/aic.2021.109834
Online publish date: 2021/10/20
View full text Get citation
 
A 47-year-old man, smoker, was transferred to the Department of Cardiology Catheterization Laboratory at the National Heart Foundation (NHF) Hospital & Research Institute [1] in Dhaka, Bangladesh, from a remote hospital after streptokinase failure to reperfuse anterior ST-elevation acute myocardial infarction (STEMI).

The patient had presented in a local hospital with a severe retrosternal pain of 6-hour duration (transportation > 2 h). A diagnosis of anterior STEMI was made. The patient received i.v. morphine (8 mg) and intravenous streptokinase (STK, 1.5 million units i.v.) as the first-line reperfusion therapy in most areas of Bangladesh. Other medications were oral aspirin (300 mg), loading dose of generic clopidogrel (300 mg), and high-dose (80 mg) generic atorvastatin, all of which are now manufactured in the country.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.